Dapagliflozin Effects on Hypoglycemia

Status Completed

Clinical Trial Summary

Clinical Trial Description

The purpose of this research study will be to test and evaluate if dapagliflozin has an effect on the amount of glucagon (a hormone produced by the pancreas and stomach that stimulates liver glucose production) produced by the body and if that change will improve recovery time from hypoglycemia (low blood sugar) in participants with Type 1 Diabetes. The study is a blinded, placebo-controlled, crossover design, where participants will receive dapagliflozin during one treatment period and placebo during a separate treatment period with neither the study team nor participants knowing what they are receiving at any given time. Participants will have 9 clinic visits over the course of 14-16 weeks, with 3 of those visits being overnight stays. The overnight stays are intended to control blood sugars in a normal state throughout the night and then participants will complete a hypoglycemic challenge the following morning. The body's response to the hypoglycemic challenge will provide the information needed to determine if dapagliflozin had an effect on recovery time from hypoglycemia. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03704818
Study type	Interventional
Source	University of California, San Diego
Contact
Status	Completed
Phase	Phase 1
Start date	October 8, 2018
Completion date	November 30, 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03623113` - The Dietary Education Trial in Carbohydrate Counting (DIET-CARB Study in Type 1 Diabetes	N/A
Withdrawn	`NCT03396484` - Methyldopa for Reduction of DQ8 Antigen Presentation in At-Risk Subjects for Type 1 Diabetes	Phase 2
Completed	`NCT03117998` - Multiple Dose Study to Evaluate the Efficacy, Safety and Pharmacodynamics of REMD-477 in Subjects With Type 1 Diabetes Mellitus	Phase 2
Recruiting	`NCT03369821` - EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)
Completed	`NCT03202732` - DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes	N/A
Recruiting	`NCT03864991` - Lifestyle Changes and Glycemic Control in T1D	N/A
Completed	`NCT03725657` - Correlation Between Exercise and Insulin Dose in a Camp for Pediatric Type 1 Patients
Completed	`NCT02985866` - The International Diabetes Closed Loop (iDCL) Trial: Protocol 1	N/A
Completed	`NCT03003806` - Evaluation of the Dreamed Advisor Pro for Automated Insulin Pump Setting Adjustments in Children and Adolescents With Type 1 Diabetes- The Advice4U Pro Study	N/A
Withdrawn	`NCT04147637` - FreeStyle Libre Plus Bluetooth Transmitter Adjunct: Can This Improve Glucose Accuracy and Reduce Burden of Hypoglycaemia	N/A
Completed	`NCT03970889` - Real-time Reminders To Decrease Late or Missed Meal Boluses	N/A
Recruiting	`NCT04589325` - Ixekizumab Diabetes Intervention Trial (I-DIT)	Phase 2
Completed	`NCT03367390` - A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM)	Phase 1
Completed	`NCT03738852` - Mechanisms for Restoration of Hypoglycemia Awareness	Early Phase 1
Completed	`NCT03406585` - Wharton´s Jelly Derived Mesenchymal Stromal Cell Treatment of Adult Patients Diagnosed With Type I Diabetes	Phase 1/Phase 2
Completed	`NCT03859856` - Ovarian Reserve in Diabetes Mellitus
Withdrawn	`NCT04102202` - BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus	Phase 1/Phase 2
Terminated	`NCT03353792` - Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients	N/A
Recruiting	`NCT03811470` - China Diabetes Registry by Metabolic Management Center
Completed	`NCT04725799` - Additional Signals for Exercise, Stress and Sleep and Prediction of Glucose Levels for AP Systems